Showing results (61-70 of 230) with videos related to

Sort By:
Pageof 23
Plos One|September 21, 2011
High throughput interrogation of somatic mutations in high grade serous cancer of the ovaryUrsula A Matulonis, Michelle Hirsch, Emanuele Palescandolo, et al.
Gynecologic Oncology|April 11, 2012
Sequential bevacizumab and oral cyclophosphamide for recurrent ovarian cancerUrsula A Matulonis, Lauren Pereira, Joyce Liu, et al.
Medrxiv : the Preprint Server for Health Sciences|February 20, 2025
Smartphone-based measures as real-world indicators of functional status in advanced cancer patientsMarcin Straczkiewicz, Nancy L Keating, Stephanie M Schonholz, et al.
Oncotarget|May 7, 2014
Sublethal concentrations of 17-AAG suppress homologous recombination DNA repair and enhance sensitivity to carboplatin and olaparib in HR proficient ovarian cancer cellsYoung Eun Choi, Chiara Battelli, Jacqueline Watson, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|February 15, 2023
Safety and management of niraparib monotherapy in ovarian cancer clinical trialsBradley J Monk, Antonio González-Martin, Lynn Buckley, et al.
Gynecologic Oncology|December 8, 2004
A phase II trial of weekly docetaxel in patients with platinum-resistant epithelial ovarian, primary peritoneal serous cancer, or fallopian tube cancerAnna Berkenblit, Michael V Seiden, Ursula A Matulonis, et al.
Future Oncology (London, England)|November 4, 2017
A review of mirvetuximab soravtansine in the treatment of platinum-resistant ovarian cancerKathleen N Moore, Lainie P Martin, David M O'Malley, et al.
The Oncologist|January 31, 2023
Phase II Trials of Iniparib (BSI-201) in Combination with Gemcitabine and Carboplatin in Patients with Recurrent Ovarian CancerRichard T Penson, Allison J Ambrosio, Christin A Whalen, et al.
The Journal of Allergy and Clinical Immunology|January 5, 2016
Risk stratification and skin testing to guide re-exposure in taxane-induced hypersensitivity reactionsMatthieu Picard, Leyla Pur, Joana Caiado, et al.
Cancer|June 24, 2010
Influence of patients' preferences and treatment site on cancer patients' end-of-life careAlexi A Wright, Jennifer W Mack, Patricia A Kritek, et al.
Pageof 23